Inherited Cancer Screening

Proactive genetic testing for inherited cancer syndromes enables a preventative approach that can facilitate life-changing interventions.

Inherited Cancer Genetics

Hereditary cancer syndromes are inherited disorders which increase an individual’s risk of developing one or several types of cancer. Approximately 5-10% of cancers are due to inherited, pathogenic mutations.

Genetic Testing for Cancer

Genetic testing is used to detect pathogenic, or disease-causing, variants associated with an increased risk for developing a hereditary cancer. The process involves sequencing specific genes to determine if any pathogenic genetic variations are present. As part of a complete risk assessment, results from this kind of genetic test can help further define an individual’s inherited genetic risk towards several types of hereditary cancer syndromes.

Who Can Benefit From Genetic Cancer Screening?

While it is a powerful tool, genetic cancer screening is not the best option for everyone. Genetic testing has limited utility for those without a family history indicative of hereditary cancer. Prior to testing, an individual should evaluate their personal and family history of cancer. This hereditary cancer risk assessment will help to determine if you can benefit from genetic testing.

Cancer Screening at LifeBrite Labs

LifeBrite Labs is an accredited laboratory that performs inherited cancer genetic testing for healthcare organizations across the United States. Our ten panels test for the most common cancers including breast, pancreatic, prostate and lung. Contact LifeBrite with any questions and learn why you should choose us for genetic testing.

invisible

this item is invisible to keep the accordion closed by default

LBL ICGx-Female Reproductive Tract Cancers Panel

Gene GHR OMIM
BRCA1
BRCA2
BRIP1
EPCAM
MLH1
MSH2
MSH6
PMS2
RAD51C
RAD51D
STK11

LBL ICGx-Breast Cancer Panel

Gene GHR OMIM
ATM
BARD1
BRCA1
BRCA2
BRIP1
CDH1
CHEK2
MRE11A
MUTYH
NBN
NF1
PALB2
PTEN
RAD50
RAD51C
STK11
TP53

LBL ICGx-Prostate Cancer Panel

Gene GHR OMIM
BRCA1
BRCA2
CHEK2
ELAC2
NBN
TP53

LBL ICGx-Pancreatic Cancer Panel

Gene GHR OMIM
APC
BRCA1
BRCA2
CDKN2A
EPCAM
MEN1
MLH1
MSH2
MSH6
PALLD
PMS2
STK11
TP53

LBL ICGx-Gastric Cancer Panel

Gene GHR OMIM
APC
BMPR1A
CDH1
EPCAM
FANCC
MLH1
MSH2
MSH6
PMS2
SMAD4
STK11

LBL ICGx-Melanoma Panel

Gene GHR OMIM
CDK4
CDKN2A

LBL ICGx-Lung Cancer Panel

Gene GHR OMIM
STK11
TP53

LBL ICGx-Renal Cancer Panel

Gene GHR OMIM
APC
EPCAM
MET
MLH1
MSH2
MSH6
MUTYH
PMS2
PTEN
TP53
VHL

LBL ICGx-Tumor Syndromes Panel

Gene GHR OMIM
FANCC
HRAS
PTCH1
RET

LBL ICGx-Comprehensive Hereditary Cancer Panel

Gene GHR OMIM
APC
ATM
BARD1
BMPR1A
BRCA1
BRCA2
BRIP1
CDH1
CDK4
CDKN2A
CHEK2
ELAC2
EPCAM
FANCC
HRAS
MEN1
MET
MLH1
MRE11A
MSH2
MSH6
MUTYH
NBN
NF1
PALB2
PALLD
PMS2
PTCH1
PTEN
RAD50
RAD51
RAD51C
RAD51D
RET
SMAD4
STK11
TP53
VHL

Sitemap

About
Testing Services
Why Choose Us
Technology
News
Contact Us

Contact Us

© 2019 LifeBrite Laboratories.
A Hospital, Laboratory, Research & Development Company